Company intelligence / Profile preview

Nycomed

city/country HQ pre-acquisition, Switzerlandtakeda.com ↗

Ownership: Private
Employees: ~12000
Development stage: Commercial

Overview

Nycomed was a major European pharmaceutical company founded in Norway in the late nineteenth century. It became internationally recognized for its innovations in diagnostic imaging agents and later expanded into specialty pharmaceuticals through acquisitions and licensing. By the time of its acquisition by Takeda, it had a broad commercial portfolio including hospital/specialty medicines and general practitioner/pharmacy products across Europe and emerging markets. Its most notable recent product was roflumilast (Daxas®), a treatment for COPD that contributed significantly to its growth strategy prior to being acquired.[2][3]

Therapeutic areas: OtherPulmonologyDermatology
Modalities: small molecules (notably radiocontrast agents and specialty pharmaceuticals)[3][6]generic drugs[3]
Industry: Pharma

Drug pipeline

1 asset

roflumilast

Commercial

Indications: Chronic obstructive pulmonary disease (COPD)

Partnerships

Extensive history of licensing new medicines from research companies for European introduction.[3]. Specific partners not listed.

Beyond the preview

Go deeper on Nycomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nycomed.

Explore the full profile